U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX11895931: GSM5534514: CT13; Mus musculus; RNA-Seq
2 ILLUMINA (Illumina HiSeq 2000) runs: 19.6M spots, 2G bases, 563.6Mb downloads

Submitted by: NCBI (GEO)
Study: Bulk RNAseq of AB1-HA murine mesothelioma tumors from complete responders and partial responders to cyclophosphamide chemotherapy
show Abstracthide Abstract
Purpose: To compare the gene expression profiles of tumors from complete responders and partial responders to cyclophosphamide chemotherapy. AB1-HA murine mesothelioma tumors were excised one day prior to cyclophosphamide or three or seven days post cyclophosphamide. Overall design: BALB/c mice bearing bilateral AB1-HA murine mesothelioma were treated 200 mg/kg cyclophosphamide. One tumor was surgically excised pre-treatment (one day prior to cyclophosphamide, day-1) or post-treatment (three or seven days after cyclophosphamide, day+3 or day+7) and RNAseq performed. The remaining tumor was used as a readout of response. For pre-treatment samples n=13 complete responders and n=13 partial responders. For post-treatment samples, n=10 complete responders and n=10 partial responders.
Sample: CT13
SAMN20960104 • SRS9907248 • All experiments • All runs
Organism: Mus musculus
Library:
Instrument: Illumina HiSeq 2000
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: SINGLE
Construction protocol: Frozen tumour dissociation with Trizol followed by chloroform extraction and purification using RNeasy MinElute Illumina 50bp single-end sequencing
Experiment attributes:
GEO Accession: GSM5534514
Links:
Runs: 2 runs, 19.6M spots, 2G bases, 563.6Mb
Run# of Spots# of BasesSizePublished
SRR155982949,645,479964.5M277.5Mb2022-08-19
SRR155982959,931,700993.2M286.1Mb2022-08-19

ID:
15813708

Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...